296 related articles for article (PubMed ID: 24857146)
1. The horizon of precision medicine in breast cancer: fragmentation, alliance, or reunification?
Andre F; Vicier C; Delaloge S
Am Soc Clin Oncol Educ Book; 2014; ():e5-10. PubMed ID: 24857146
[TBL] [Abstract][Full Text] [Related]
2. [BREAST CANCER: FROM TARGETED THERAPY TO PRECISION MEDICINE].
Jerusalem G; Collignon J; Josse C; Schroeder H; Rorive A; Frères P; Lambert F; Koopmansch B; Poncin A; Bours V
Rev Med Liege; 2015; 70(5-6):269-76. PubMed ID: 26285451
[TBL] [Abstract][Full Text] [Related]
3. Target therapy for metastatic breast cancer.
Rachdi H; Mokrani A; Batti R; Ayadi M; Chraiet N; Mezlini A
Tunis Med; 2018; 96(8-9):465-471. PubMed ID: 30430522
[TBL] [Abstract][Full Text] [Related]
4. Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?
Berrada N; Delaloge S; André F
Ann Oncol; 2010 Oct; 21 Suppl 7():vii30-5. PubMed ID: 20943632
[TBL] [Abstract][Full Text] [Related]
5. Is precision medicine ready for use in breast cancer?
Pusztai L
Clin Adv Hematol Oncol; 2016 Dec; 14(12):964-966. PubMed ID: 28212357
[No Abstract] [Full Text] [Related]
6. Successes and limitations of targeted cancer therapy in breast cancer.
Curigliano G; Criscitiello C
Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
[TBL] [Abstract][Full Text] [Related]
7. Precision Medicine and Targeted Therapies in Breast Cancer.
Greenwalt I; Zaza N; Das S; Li BD
Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
[TBL] [Abstract][Full Text] [Related]
8. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
Coyne GO; Takebe N; Chen AP
Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine for advanced prostate cancer.
Mullane SA; Van Allen EM
Curr Opin Urol; 2016 May; 26(3):231-9. PubMed ID: 26909474
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
Stover DG; Wagle N
Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine for metastatic breast cancer.
Deluche E; Onesti E; Andre F
Am Soc Clin Oncol Educ Book; 2015; ():e2-7. PubMed ID: 25993174
[TBL] [Abstract][Full Text] [Related]
12. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy in cancer.
Tsimberidou AM
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
[TBL] [Abstract][Full Text] [Related]
14. Precision Medicine in Pediatric Oncology.
Vo KT; Parsons DW; Seibel NL
Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
[TBL] [Abstract][Full Text] [Related]
15. Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy.
Vasmatzis G; Liu MC; Reganti S; Feathers RW; Smadbeck J; Johnson SH; Schaefer Klein JL; Harris FR; Yang L; Kosari F; Murphy SJ; Borad MJ; Thompson EA; Cheville JC; Anastasiadis PZ
Mayo Clin Proc; 2020 Feb; 95(2):306-318. PubMed ID: 31685261
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.
Smith B; Agarwal P; Bhowmick NA
Endocr Relat Cancer; 2017 May; 24(5):R157-R172. PubMed ID: 28289080
[TBL] [Abstract][Full Text] [Related]
17. Precision medicine for metastatic breast cancer--limitations and solutions.
Arnedos M; Vicier C; Loi S; Lefebvre C; Michiels S; Bonnefoi H; Andre F
Nat Rev Clin Oncol; 2015 Dec; 12(12):693-704. PubMed ID: 26196250
[TBL] [Abstract][Full Text] [Related]
18. Management and Outcomes in Metaplastic Breast Cancer.
Tzanninis IG; Kotteas EA; Ntanasis-Stathopoulos I; Kontogianni P; Fotopoulos G
Clin Breast Cancer; 2016 Dec; 16(6):437-443. PubMed ID: 27431460
[TBL] [Abstract][Full Text] [Related]
19. Toward precision medicine in glioblastoma: the promise and the challenges.
Prados MD; Byron SA; Tran NL; Phillips JJ; Molinaro AM; Ligon KL; Wen PY; Kuhn JG; Mellinghoff IK; de Groot JF; Colman H; Cloughesy TF; Chang SM; Ryken TC; Tembe WD; Kiefer JA; Berens ME; Craig DW; Carpten JD; Trent JM
Neuro Oncol; 2015 Aug; 17(8):1051-63. PubMed ID: 25934816
[TBL] [Abstract][Full Text] [Related]
20. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
Liang ZM; Chen Y; Luo ML
Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
